• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.对马利巴韦的耐药性与人类巨细胞病毒感染期间 pUL27 从核仁中的排除有关。
Antiviral Res. 2011 Nov;92(2):313-8. doi: 10.1016/j.antiviral.2011.08.019. Epub 2011 Sep 1.
2
Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.人巨细胞病毒感染期间pUL27与pUL97活性之间的拮抗关系
J Virol. 2015 Oct;89(20):10230-46. doi: 10.1128/JVI.00986-15. Epub 2015 Jul 29.
3
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance.来特莫韦和马拉韦罗的临床研发:人巨细胞病毒耐药性概述。
Antiviral Res. 2019 Mar;163:91-105. doi: 10.1016/j.antiviral.2019.01.011. Epub 2019 Jan 25.
4
Conserved domains and structure prediction of human cytomegalovirus UL27 protein.人类巨细胞病毒UL27蛋白的保守结构域及结构预测
Antivir Ther. 2009;14(5):663-72.
5
Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.多种巨细胞病毒UL27突变可适应在马里巴韦作用下病毒UL97激酶活性的丧失。
Antimicrob Agents Chemother. 2009 Jan;53(1):81-5. doi: 10.1128/AAC.01177-08. Epub 2008 Nov 3.
6
Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir.人巨细胞病毒 UL27 基因中赋予对马立巴韦耐药性的突变。
J Virol. 2004 Jul;78(13):7124-30. doi: 10.1128/JVI.78.13.7124-7130.2004.
7
Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo.体外和体内药物暴露后检测到的巨细胞病毒 UL97 激酶 ATP 结合区域突变对马拉韦罗敏感性的影响。
Antiviral Res. 2012 Aug;95(2):88-92. doi: 10.1016/j.antiviral.2012.05.013. Epub 2012 Jun 1.
8
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.巨细胞病毒核酸外切酶结构域II突变体中马里巴韦耐药性的加速演变
J Virol. 2008 Jan;82(1):246-53. doi: 10.1128/JVI.01787-07. Epub 2007 Oct 17.
9
Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.人巨细胞病毒对苯并咪唑L-核糖核苷马里巴韦的耐药性定位到UL27。
J Virol. 2003 Nov;77(21):11499-506. doi: 10.1128/jvi.77.21.11499-11506.2003.
10
Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.细胞 STAT3 的抑制与巨细胞病毒激酶抑制剂马拉维若联合作用,破坏感染。
Antiviral Res. 2013 Nov;100(2):321-7. doi: 10.1016/j.antiviral.2013.09.011. Epub 2013 Sep 23.

引用本文的文献

1
Insights into the Transcriptome of Human Cytomegalovirus: A Comprehensive Review.人类巨细胞病毒转录组的研究进展:全面综述。
Viruses. 2023 Aug 8;15(8):1703. doi: 10.3390/v15081703.
2
Cytomegalovirus Late Protein pUL31 Alters Pre-rRNA Expression and Nuclear Organization during Infection.巨细胞病毒晚期蛋白pUL31在感染过程中改变前体核糖体RNA表达和细胞核组织。
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00593-17. Print 2017 Sep 15.
3
Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with Cytomegalovirus.免疫功能低下的小儿巨细胞病毒感染患者低频多药耐药性及新型假定的马里巴韦耐药性的检测
Front Microbiol. 2016 Sep 9;7:1317. doi: 10.3389/fmicb.2016.01317. eCollection 2016.
4
Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.人巨细胞病毒感染期间pUL27与pUL97活性之间的拮抗关系
J Virol. 2015 Oct;89(20):10230-46. doi: 10.1128/JVI.00986-15. Epub 2015 Jul 29.
5
Novel method based on "en passant" mutagenesis coupled with a gaussia luciferase reporter assay for studying the combined effects of human cytomegalovirus mutations.基于“顺式”突变与海肾荧光素酶报告基因检测联合研究人巨细胞病毒突变的协同作用的新方法。
J Clin Microbiol. 2013 Oct;51(10):3216-24. doi: 10.1128/JCM.01275-13. Epub 2013 Jul 17.
6
Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo.体外和体内药物暴露后检测到的巨细胞病毒 UL97 激酶 ATP 结合区域突变对马拉韦罗敏感性的影响。
Antiviral Res. 2012 Aug;95(2):88-92. doi: 10.1016/j.antiviral.2012.05.013. Epub 2012 Jun 1.
7
Progress in the development of new therapies for herpesvirus infections.疱疹病毒感染新疗法的研究进展。
Curr Opin Virol. 2011 Dec;1(6):548-54. doi: 10.1016/j.coviro.2011.10.015.

本文引用的文献

1
Cytomegalovirus: pathogen, paradigm, and puzzle.巨细胞病毒:病原体、范例和谜题。
J Clin Invest. 2011 May;121(5):1673-80. doi: 10.1172/JCI45449.
2
Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.靶向 HCMV 激酶 pUL97 的抗病毒抑制作用需要 pUL27 依赖性降解 Tip60 乙酰转移酶和细胞周期停滞。
Cell Host Microbe. 2011 Feb 17;9(2):103-14. doi: 10.1016/j.chom.2011.01.006.
3
The search for new therapies for human cytomegalovirus infections.寻找人类巨细胞病毒感染的新疗法。
Virus Res. 2011 May;157(2):212-21. doi: 10.1016/j.virusres.2010.11.004. Epub 2010 Nov 21.
4
Antiviral drug resistance of human cytomegalovirus.人巨细胞病毒的抗病毒药物耐药性。
Clin Microbiol Rev. 2010 Oct;23(4):689-712. doi: 10.1128/CMR.00009-10.
5
En passant mutagenesis: a two step markerless red recombination system.逐代诱变:一种两步无标记红色重组系统。
Methods Mol Biol. 2010;634:421-30. doi: 10.1007/978-1-60761-652-8_30.
6
Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.巨细胞病毒 UL97 激酶序列变异体的重组表型分析与更昔洛韦耐药性的关系。
Antimicrob Agents Chemother. 2010 Jun;54(6):2371-8. doi: 10.1128/AAC.00186-10. Epub 2010 Apr 12.
7
Signaling to p53: ribosomal proteins find their way.向p53发出信号:核糖体蛋白找到其作用途径。
Cancer Cell. 2009 Nov 6;16(5):369-77. doi: 10.1016/j.ccr.2009.09.024.
8
Nucleolar disruption impairs Kaposi's sarcoma-associated herpesvirus ORF57-mediated nuclear export of intronless viral mRNAs.核仁破裂会损害卡波氏肉瘤相关疱疹病毒 ORF57 介导的无内含子病毒 mRNAs 的核输出。
FEBS Lett. 2009 Nov 19;583(22):3549-56. doi: 10.1016/j.febslet.2009.10.040. Epub 2009 Oct 20.
9
Involvement of the nucleolus in replication of human viruses.核仁在人类病毒复制中的作用。
Rev Med Virol. 2009 Jul;19(4):201-14. doi: 10.1002/rmv.614.
10
In search of nonribosomal nucleolar protein function and regulation.探索非核糖体核仁蛋白的功能与调控。
J Cell Biol. 2009 Mar 23;184(6):771-6. doi: 10.1083/jcb.200812014. Epub 2009 Mar 16.

对马利巴韦的耐药性与人类巨细胞病毒感染期间 pUL27 从核仁中的排除有关。

Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection.

机构信息

Division of Infectious Diseases, Oregon Health & Science University, Portland, OR 97239, USA.

出版信息

Antiviral Res. 2011 Nov;92(2):313-8. doi: 10.1016/j.antiviral.2011.08.019. Epub 2011 Sep 1.

DOI:10.1016/j.antiviral.2011.08.019
PMID:21906628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3232008/
Abstract

Select mutations in the human cytomegalovirus (HCMV) gene UL27 confer low-grade resistance to the HCMV UL97 kinase inhibitor maribavir (MBV). It has been reported that the 608-amino acid UL27 gene product (pUL27) normally localizes to cell nuclei and nucleoli, whereas its truncation at codon 415, as found in a MBV-resistant mutant, results in cytoplasmic localization. We now show that in the context of full-length pUL27, diverse single amino acid substitutions associated with MBV resistance result in loss of its nucleolar localization when visualized after transient transfection, whereas substitutions representing normal interstrain polymorphism had no such effect. The same differences in localization were observed during a complete infection cycle with recombinant HCMV strains over-expressing full-length fluorescent pUL27 variants. Nested UL27 C-terminal truncation expression plasmids showed that amino acids 596-599 were required for the nucleolar localization of pUL27. These results indicate that the loss of a nucleolar function of pUL27 may contribute to MBV resistance, and that the nucleolar localization of pUL27 during HCMV infection depends not only on a carboxy-terminal domain but also on a property of pUL27 that is affected by MBV-resistant mutations, such as an interaction with component(s) of the nucleolus.

摘要

人类巨细胞病毒(HCMV)基因 UL27 的选择突变赋予 HCMV UL97 激酶抑制剂缬更昔洛韦(MBV)低度耐药性。据报道,正常情况下,608 个氨基酸的 UL27 基因产物(pUL27)定位于细胞核和核仁,而在 MBV 耐药突变体中发现的密码子 415 处截断导致细胞质定位。我们现在表明,在全长 pUL27 的情况下,与 MBV 耐药性相关的多种单一氨基酸取代导致瞬时转染后其核仁定位丧失,而代表正常种间多态性的取代则没有这种作用。在用过表达全长荧光 pUL27 变体的重组 HCMV 株进行完整感染周期期间,观察到相同的定位差异。嵌套的 UL27 C 末端截断表达质粒表明,pUL27 的核仁定位需要氨基酸 596-599。这些结果表明,pUL27 的核仁功能丧失可能导致 MBV 耐药性,并且 HCMV 感染期间 pUL27 的核仁定位不仅取决于羧基末端结构域,还取决于 pUL27 的一种特性,该特性受 MBV 耐药性突变的影响,例如与核仁成分(s)的相互作用。